Be wary of drug ads
Roughly two-thirds of the 150 top-selling prescription drugs sold in 2020 had low “added clinical benefit” compared to existing drugs. (Those ratings come from France or Canada. The U.S. doesn’t rate drug benefits.)
Continue reading this article with a NutritionAction subscription
Already a subscriber? Log in